| Endpoint details |
---|---|
Primary endpoint | Change in of NT-proBNP level from baseline to 6 months after randomization |
Secondary endpoints | The frequency of NT-proBNP increment > 10% from baseline |
Composite of all-cause mortality and readmission | |
All-cause mortality rate and readmission rate | |
Change in systolic/diastolic blood pressure at sitting position, control/response rate of blood pressure | |
Quality of life assessment by the MLHFQ, Visual Analog Scale | |
Drug compliance |